Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex

Journal of Clinical Microbiology

Volumn 47, Issue 11, 2009, Pages 3630-3634

  Lin, S Y Grace ^a   Desmond, Edward ^a   Bonato, Donald ^b   Gross, Wendy ^b   Siddiqi, Salman ^c  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c BD Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; ETHIONAMIDE; LEVOFLOXACIN;

ARTICLE; BACTERIAL STRAIN; DRUG SENSITIVITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

AMIKACIN; ANTITUBERCULAR AGENTS; CAPREOMYCIN; ETHIONAMIDE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS COMPLEX;

EID: 70449646620     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00803-09     Document Type: Article

References (25)

1. Banerjee, R., G. F. Schecter, J. Flood, and T. C. Porco. 2008. Extensively drug-resistant tuberculosis: new strains, new challenges. Exp. Rev. Anti-Infect. Ther. 6:713-724.
2. Bang, D., A. Bengard Andersen, and V. O. Thomsen. 2006. Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. J. Clin. Microbiol. 44:2605-2608.
3. Barnard, M., H. Albert, G. Coetzee, R. O'Brien, and M. E. Bosman. 2008. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am. J. Respir. Crit. Care Med. 177:787-792.
4. Bemer, P., F. Palicova, S. Rusch-Gerdes, H. B. Drugeon, and G. E. Pfyffer. 2002. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 40:150-154. (Pubitemid 34027617)
5. Centers for Disease Control and Prevention. 2006. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. MMWR Morb. Mortal. Wkly. Rep. 55:301-305.
6. Hillemann, D., S. Rusch-Gerdes, and E. Richter. 2007. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 45:2635-2640.
7. Johansen, I. S., B. Lundgren, A. Sosnovskaja, and V. O. Thomsen. 2003. Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay. J. Clin. Microbiol. 41:4454-4456.
8. Kim, S. J. 2005. Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur. Respir. J. 25:564-569.
9. Kruuner, A., M. D. Yates, and F. A. Drobniewski. 2006. Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis. J. Clin. Microbiol. 44:811-818.
10. Lefford, M. J., and D. A. Mitchison. 1966. Comparison of methods for testing the sensitivity of Mycobacterium tuberculosis to ethionamide. Tubercle (London) 47:250-262.
11. Lin, S. Y. G., W. Probert, M. Lo, and E. Desmond. 2004. Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons. J. Clin. Microbiol. 42:4204-4208.
12. Martin, A., A. von Groll, K. Fissette, J. C. Palomino, F. Varaine, and F. Portaels. 2008. Rapid detection of Mycobacterium tuberculosis resistance to second-line drugs by use of the manual Mycobacterium Growth Indicator Tube system. J. Clin. Microbiol. 46:3952-3956.
13. Mikhailovich, V., S. Lapa, D. Gryadunov, A. Sobolev, B. Strizhkov, N. Chernyh, O. Skotnikova, O. Irtuganova, A. Moroz, V. Litvinov, M. Vladimirskii, M. Perelman, L. Chernousova, V. Erokhin, A. Zasedatelev, and A. Mirzabekov. 2001. Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and ligase detection reaction on oligonucleotide microchips. J. Clin. Microbiol. 39:2531-2540.
14. Reference deleted.
15. Pfyffer, G. E., D. A. Bonato, A. Ebrahimzadeh, W. Gross, J. Hotaling, J. Kornblum, A. Laszlo, G. Roberts, M. Salfinger, F. Wittwer, and S. Siddiqi. 1999. Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J. Clin. Microbiol. 37:3179-3186.
16. Raviglione, M. C., and I. M. Smith. 2007. XDR tuberculosis - implications for global public health. N. Engl. J. Med. 356:656-659.
17. Rodrigues, C., J. Jani, S. Shenai, P. Thakkar, S. Siddiqui, and A. Mehta. 2008. Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. Int. J. Tuberc. Lung Dis. 12:1449-1455.
18. Rusch-Gerdes, S., G. E. Pfyffer, M. Casal, M. Chadwick, and S. Siddiqi. 2006. Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J. Clin. Microbiol. 44:688-692.
19. Sanders, C. A., R. R. Nieda, and E. P. Desmond. 2004. Validation of the use of Middlebrook 7H10 agar, BACTEC MGIT 960, and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin. J. Clin. Microbiol. 42:5225-5228.
20. Scarparo, C., P. Ricordi, G. Ruggiero, and P. Piccoli. 2004. Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method. J. Clin. Microbiol. 42:1109-1114.
21. Shah, N. S., A. Wright, G. H. Bai, L. Barrera, F. Boulahbal, N. Martin-Casabona, F. Drobniewski, C. Gilpin, M. Havelkova, R. Lepe, R. Lumb, B. Metchock, F. Portaels, M. F. Rodrigues, S. Rusch-Gerdes, A. Van Deun, V. Vincent, K. Laserson, C. Wells, and J. P. Cegielski. 2007. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg. Infect. Dis. 13:380-387.
22. Tenover, F. C., J. T. Crawford, R. E. Huebner, L. J. Geiter, C. R. Horsburgh, Jr., and R. C. Good. 1993. The resurgence of tuberculosis: is your laboratory ready? J. Clin. Microbiol. 31:767-770.
23. Tortoli, E., M. Benedetti, A. Fontanelli, and M. T. Simonetti. 2002. Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion. J. Clin. Microbiol. 40:607-610.
24. World Health Organization. 2008. Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs. WHO/HTM/TB/2008.392. WHO, Geneva, Switzerland.
25. World Health Organization. 2007. Use of liquid TB culture and drug susceptibility testing (DST) in low and medium income settings. Summary report of the expert group meeting on the use of liquid culture media. 26 March 2007. WHO, Geneva, Switzerland.